Submission of contributions All manuscripts must be submitted through the online system at http://ees.elsevier.com/bcp/.
Manuscripts mailed to the editorial office will not be processed. Registration is required if using the system for the first
time. After accessing the web site click on the "Register" link located towards the middle of the top of the screen. Detailed
instructions are provided by clicking on the "Tutorial for Authors" link in the grey Author Information box in the upper right corner
of screen.
The cover letter must contain a statement assuring that the material has not been published or is under active consideration
by another journal. The authors must also indicate in the cover letter that the research was conducted in accordance with the Declaration
of Helsinki and/or with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the United States National
Institutes of Health.
Conflict of Interest Statement. Authors are requested to disclose any possible conflicts of interest. Affiliation
of authors submitting manuscripts in their role as members of industrial or government organizations may constitute sufficient disclosure.
Academic, nonprofit, consulting, advocacy, and all other authors are asked to disclose in a footnote all sources of financial and material
support for the studies and manuscripts submitted.
Form of Contributions
Reports must be written in English and include
an abstract that does not exceed 250 words. Manuscript pages should be numbered sequentially and double-spaced with 1" or 25 mm margins.
Size 12 (point) Times Roman or Arial font is preferred. Corresponding author contact information, including e-mail address, telephone,
fax number, and full postal address must be provided on the title page. Research articles must be divided into the following sections:
Abstract, Introduction, Materials and Methods, Results, Discussion, References, Acknowledgments, and figure legends. Copies of articles
cited as in press or submitted must be included with the manuscript. Do not split the manuscript into separate files for each section.
Ensure that the letter 'l' and digit '1' and the letter 'O' and digit '0' are used properly, and that the printed format (indentions,
headings, etc.) is consistent throughout. Characters not available on your word processor, such as Greek letters, must be indicated by
a code, such as gralpha, @, or # for α. Such codes must be used consistently throughout the text. Please provide the key to the code
with the submission. Do not allow your word processor to introduce word splits and do not use a 'justified' layout. Please adhere strictly
to the general instructions on style/arrangement and, in particular, the reference style of the journal. It is critical that files be
saved in the word processor format. Do not use 'flat ASCII' for this purpose.
Since commentary articles are commissioned, instructions
to authors are provided by the editor responsible for recruiting the work.
US National Institutes of Health (NIH) voluntary posting
(" Public Access") policy
Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH "Public
Access Policy"; see http://www.nih.gov/about/publicaccess/index.htm)
by posting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, 12 months after formal publication.
Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com)
that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to
facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that
will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully
to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is
prohibited.
Language Biochemical Pharmacology is committed to the publication of science from its designated fields of interest, irrespective of
geographical and sponsor source. The peer review process routinely conducted by the Editorial Board and expert reviewers, is dedicated
to constructive, collegial feedback with the aim of improving the content and clarity of submissions. The Editorial Board and its reviewers
will however not undertake to provide major revisions of the grammatical content of submitted manuscripts, irrespective of the scientific
merit. Accordingly, authors are advised to ensure that their manuscripts are written in clear, understandable English before submitting
these to the journal. A list of language editing companies offering editing services to authors at competitive rates can be found HERE. Biochemical Pharmacology will rapidly reject those manuscripts that lack linguistic
clarity and those in which there has been minimal attempt to follow the style guidelines.
Classification
Authors must
assign the manuscript to one of the following categories at the time of submission:
(1) Antibiotics and Chemotherapeutics
(2)
Cardiovascular Pharmacology
(3) Endocrine Pharmacology
(4) Gastrointestinal Pharmacology
(5) Inflammation and Immunopharmacology
(6) Toxicology
(7) Neuropharmacology
(8) Pharmacokinetics and Drug Metabolism
(9) Pulmonary, Renal and Hepatic Pharmacology
The category must be listed on the title page.
Supplementary Data Preparation of supplementary data. Elsevier
accepts supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities
to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary
files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data
is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article
and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages
at http://www.elsevier.com/artworkinstructions
Nomenclature and Abbreviations
Use only nomenclature and
abbreviations that are generally accepted by the scientific community. Those abbreviations that can be employed without definition are
listed in issues 1 and 7 of each volume. Drugs or other xenobiotics should be identified only by their chemical or generic names. The
source, including company name and location, for all chemicals, reagents, cell lines, tissue, and experimental animals must be provided
in the text.
Gene accession numbers can be found in the databases at the National Center for Biotechnical Information (NCBI) at
the National Library of Medicine. Every accession number cited in an article should be typed in bold, underlined text.
Letters in the accession number should always be capitalized.
Example: a B-cell tumor from a chronic lymphatic leukemia (GenBank
accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)
Figures
Line
drawings, including graphs, should be black on a white background. Lettering should be large enough to permit photographic reduction.
For those not to be reduced, the format should not exceed 16x20 cm. Photographs (or halftone illustrations) must be of good quality with
as much contrast as possible. The magnification of micrographs should be indicated by a scale bar in the figure. Illustrations should
be numbered with Arabic numerals. The legends should be typed separately with double spacing. Color figures will be published free of
charge on the web version of the work, even if they do not appear as color in the print version. Information regarding the cost of color
figures in print is supplied to the corresponding author if the article is accepted for publication. Because of technical limitations
associated with converting color figures to greyscale, please submit black and white prints of color illustrations that are not going
to appear in color in the print version of the work.
Additional information on the preparation of electronic artwork may be found at
http://www.elsevier.com/locate/authorartwork.
Tables
All tables must be numbered consecutively in Arabic
numerals and cited in the text. Titles should be brief but descriptive. Tables should be compiled on separate pages, together with a
legend and/or footnotes. Tables should not have vertical lines, and horizontal lines must be kept to a minimum.
References
References should be numbered consecutively in square brackets in the text, with the full reference provided in a numbered list at the
end of the paper. Unpublished results and personal communications must not appear in the reference list, but rather be included in the
text. References should contain the names and initials of the first six authors only, followed by et al. if necessary, along with the
complete title of the work, the abbreviated journal title, the year, volume number, and inclusive page numbers. Examples of the reference
format are shown below: Articles in Special Issues: Please ensure that the words 'this issue' are added (in the
list and text) to any references to other articles in this Special Issue. Journal
[1] Reiter R, Burk RF. Effect of
oxygen tension on the generation of alkanes and malondialdehyde by peroxidizing rat liver microsomes. Biochem Pharmacol 1987;36:925-9. Book
[2] Winer BJ. Statistical principles in experimental design. New York: McGraw-Hill, 1971. Chapter in a book
[3] Shatkin AJ. Colorimetric reactions for DNA, RNA, and protein determinations. In: Habel K, Salzman NP, editors. Fundamental techniques
in virology. New York: Academic Press, 1969. p. 231:7. Symposium proceedings
[4] Wefers H, Sies H. Generation of photoemissive
species during quinone redox cycling. In: Alexander P, editor. Bioreduction in the Activation of Drugs, Proceedings of the Second Biochemical
Pharmacology Symposium, Oxford, UK, 25-26 July 1985. Oxford: Pergamon Press, 1986. p. 22-4.
The Index Medicus abbreviations should
be used for journal titles.
Footnotes
Footnotes, which should be used sparingly, are numbered consecutively throughout
the text using superscript Arabic numerals. If the footnotes are not automatically built into the text, indicate the position of each
in the text and provide the footnotes on a separate page at the end of the article. Do not include footnotes in the reference list.
Indicate
each table footnote with a superscript lowercase letter. Symbols indicating author affiliations should be superscript letters, with an
asterisk indicating the corresponding author.
Proofs
Proofs are sent as PDFs by e-mail. Hard copies of the proofs can
be sent for correction if the author prefers. All corrections to the proofs must be included in a single communication. Only typesetting
errors may be corrected on proofs. There can be no changes in, or additions to, the accepted manuscript at the proof
stage. Proofs must be returned to Elsevier within 48 hours of receipt.
Offprints
Twenty-five offprints of each published
article are provided free of charge. Additional copies may be ordered using the offprint order form sent to the author. Offprints ordered
after the article has appeared in print will cost considerably more than those ordered prior to publication.
Page Charges
There are no page charges for articles published in Biochemical Pharmacology.
